Inventor · disambiguated record
In-Gyu Je
Also filed as: JE IN GYU
3 granted patents·5 pending applications·3 citations·filing 2020–2023
54Inventor score
Top patents by PatentIndex Score
8 records- 0189US11643403B2GLP-1 receptor agonist and use thereofILDONG PHARMACEUTICAL CO LTD·Filed 2020·Granted May 9, 2023·3 cites·14 claims
- 0268US11932618B2GLP-1 receptor agonist and use thereofILDONG PHARMACEUTICAL CO LTD·Filed 2023·Granted Mar 19, 2024·0 cites·15 claims
- 0366US2023373954A1Novel acid secretion inhibitor and use thereofILDONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0463US11767311B2Acid secretion inhibitor and use thereofILDONG PHARMACEUTICAL CO LTD·Filed 2021·Granted Sep 26, 2023·0 cites·9 claims
- 0558US2025214968A1Novel Salt of GLP-1 Receptor Agonist Compound, Preparation Method Thereof and Pharmaceutical Composition Comprising ThereofILDONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0655US2024366579A1Pharmaceutical composition comprising gpr40 agonist and sglt-2 inhibitorILDONG PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0753US2022409598A1Method of controlling blood sugar level and treatment of diabetes and related conditionsILDONG PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0853US2025120970A1Pharmaceutical composition including phthalazinone derivative for co-administration with anticancer drugIDIENCE CO LTD·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when In-Gyu Je files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →